1 Kashyap, SR & Defronzo, RA (2007) The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 4, 13–19.
2 Riksen, NP, Rongen, GA & Smits, P (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121, 185–191.
3 Moisey, LL, Kacker, S, Bickerton, AC, et al. (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87, 1254–1261.
4 Keijzers, GB, De Galan, BE, Tack, CJ, et al. (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364–369.
5 van Dam, RM, Willett, WC, Manson, JE, et al. (2006) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29, 398–403.
6 van Dam, RM & Feskens, EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360, 1477–1478.
7 Noordzij, M, Uiterwaal, CS, Arends, LR, et al. (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23, 921–928.
8 Jee, SH, He, J, Whelton, PK, et al. (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33, 647–652.
9 Geleijnse, JM (2008) Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag 4, 963–970.
10 Conde, SV, Pinto, P, Bárbara, C, et al. (2009) Should caffeine be avoided in obstructive sleep apnea? In European Respiratory Society Annual Congress, Vienna, Austria: 2009. .
11 Arnlov, J, Vessby, B & Riserus, U (2004) Coffee consumption and insulin sensitivity. JAMA 291, 1199–1201.
12 Greenberg, JA, Boozer, CN & Geliebter, A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84, 682–693.
13 Zheng, G, Sayama, K, Okubo, T, et al. (2004) Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 18, 55–62.
14 Lopez-Garcia, E, van Dam, RM, Rajpathak, S, et al. (2006) Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83, 674–680.
15 Greenberg, JA, Axen, KV, Schnoll, R, et al. (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29, 1121–1129.
16 Wu, T, Willett, WC, Hankinson, SE, et al. (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28, 1390–1396.
17 Cheung, WT, Lee, CM & Ng, TB (1988) Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology 36, 331–339.
18 Astrup, A, Breum, L, Toubro, S, et al. (1992) The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 16, 269–277.
19 Sung, BH, Whitsett, TL, Lovallo, WR, et al. (1994) Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men. Am J Hypertens 7, 755–758.
20 Sung, BH, Lovallo, WR, Whitsett, T, et al. (1995) Caffeine elevates blood pressure response to exercise in mild hypertensive men. Am J Hypertens 8, 1184–1188.
21 Pincomb, GA, Lovallo, WR, McKey, BS, et al. (1996) Acute blood pressure elevations with caffeine in men with borderline systemic hypertension. Am J Cardiol 77, 270–274.
22 Benowitz, NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41, 277–288.
23 Fredholm, BB, Battig, K, Holmen, J, et al. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51, 83–133.
24 Robertson, D, Wade, D, Workman, R, et al. (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67, 1111–1117.
25 Myers, MG (1988) Effects of caffeine on blood pressure. Arch Intern Med 148, 1189–1193.
26 Holtzman, SG & Finn, IB (1988) Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 29, 411–418.
27 Gasior, M, Shoaib, M, Yasar, S, et al. (1999) Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288, 1053–1073.
28 Shearer, J, Severson, DL, Su, L, et al. (2009) Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo. J Pharmacol Exp Ther 328, 306–311.
29 Ribeiro, RT, Lautt, WW, Legare, DJ, et al. (2005) Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 48, 976–983.
30 Gasior, M, Jaszyna, M, Munzar, P, et al. (2002) Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psychopharmacology (Berl) 162, 385–395.
31 Rodriguez-Perez, JC, Losada, A, Anabitarte, A, et al. (1997) Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. J Pharmacol Exp Ther 283, 336–344.
32 Monzillo, LU & Hamdy, O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61, 397–412.
33 Kim, SP, Ellmerer, M, Van Citters, GW, et al. (2003) Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52, 2453–2460.
34 Ismail, NA, El Denshary, EE & Montague, W (1977) Adenosine and the regulation of insulin secretion by isolated rat islets of Langerhans. Biochem J 164, 409–413.
35 Kanazawa, M, Xue, CY, Kageyama, H, et al. (2003) Effects of a high-sucrose diet on body weight, plasma triglycerides, and stress tolerance. Nutr Rev 61, S27–S33.
36 Delarue, J & Magnan, C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10, 142–148.
37 Lewis, GF, Carpentier, A, Adeli, K, et al. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23, 201–229.
38 Egawa, T, Hamada, T, Kameda, N, et al. (2009) Caffeine acutely activates 5′adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles. Metabolism 58, 1609–1617.
39 Raney, MA & Turcotte, LP (2008) Evidence for the involvement of CaMKII and AMPK in Ca2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J Appl Physiol 104, 1366–1373.
40 Dhalla, AK, Chisholm, JW, Reaven, GM, et al. (2009) A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 193, 271–295.
41 Espinal, J, Challiss, RA & Newsholme, EA (1983) Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett 158, 103–106.
42 Han, DH, Hansen, PA, Nolte, LA, et al. (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47, 1671–1675.
43 Vergauwen, L, Hespel, P & Richter, EA (1994) Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93, 974–981.
44 Rusing, D, Muller, CE & Verspohl, EJ (2006) The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol 58, 1639–1645.
45 Figler, RA, Wang, G, Srinivasan, S, et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes 60, 669–679.
46 Umemura, T, Ueda, K, Nishioka, K, et al. (2006) Effects of acute administration of caffeine on vascular function. Am J Cardiol 98, 1538–1541.
47 Scharf, G, Prustomersky, S & Huber, WW (2001) Elevation of glutathione levels by coffee components and its potential mechanisms. Adv Exp Med Biol 500, 535–539.
48 Varma, SD & Hegde, KR (2010) Prevention of oxidative damage to lens by caffeine. J Ocul Pharmacol Ther 26, 73–77.
49 Mytilineou, C, Kramer, BC & Yabut, JA (2002) Glutathione depletion and oxidative stress. Parkinsonism Relat Disord 8, 385–387.
50 Jackisch, R, Fehr, R & Hertting, G (1985) Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology 24, 499–507.
51 Tseng, CJ, Chan, JY, Lo, WC, et al. (2001) Modulation of catecholamine release by endogenous adenosine in the rat adrenal medulla. J Biomed Sci 8, 389–394.
52 Robertson, D, Frolich, JC, Carr, RK, et al. (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298, 181–186.
53 Debrah, K, Haigh, R, Sherwin, R, et al. (1995) Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 89, 475–480.
54 Carella, AM, Antonucci, G, Conte, M, et al. (2010) Antihypertensive treatment with β-blockers in the metabolic syndrome: a review. Curr Diabetes Rev 6, 215–221.
55 Bhatt, P, Makwana, D, Santani, D, et al. (2007) Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with l-thyroxin-induced hyperthyroidism – an experimental study. Can J Physiol Pharmacol 85, 514–520.
56 Kveiborg, B, Christiansen, B, Major-Petersen, A, et al. (2006) Metabolic effects of β-adrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs 6, 209–217.
57 Corsetti, G, Pasini, E, Assanelli, D, et al. (2007) Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles. Pharmacol Res 55, 96–103.
58 Ofluoglu, E, Pasaoglu, H & Pasaoglu, A (2009) The effects of caffeine on l-arginine metabolism in the brain of rats. Neurochem Res 34, 395–399.
59 Guarino, MP & Macedo, MP (2006) Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 147, 959–965.
60 Guarino, MP, Correia, NC, Raposo, J, et al. (2001) Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside. Proc West Pharmacol Soc 44, 25–26.
61 Shi, D & Daly, JW (1999) Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol 19, 719–732.
62 Stonehouse, AH, Adachi, M, Walcott, EC, et al. (2003) Caffeine regulates neuronal expression of the dopamine 2 receptor gene. Mol Pharmacol 64, 1463–1473.